These results provide novel insight into the molecular mechanisms underlying the anti-obesity effects of AWL that are mediated by the downregulation of the expression of major adipogenic transcription factors, C/EBPα and PPARγ and Akt signalling. The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.